{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:15:59Z","timestamp":1788437759687,"version":"build-2803163510"},"reference-count":34,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"mylife Diabetes Care AG"},{"name":"NIHR, Medical Research Council"},{"name":"Diabetes Research and Wellness Foundation","award":["Sutherland-Earl Clinical Fellowship (SECF\/21)"],"award-info":[{"award-number":["Sutherland-Earl Clinical Fellowship (SECF\/21)"]}]},{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Aim:<\/jats:title>\n                    <jats:p>The CamAPS FX automated insulin delivery (AID) system is extensively evaluated and uniquely tailored for T1D pregnancies. This study evaluated the clinical and economic implications of improving glycemia with CamAPS FX AID compared with the current standard of care (SoC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cost-consequence model was built leveraging data from the AiDAPT study and was adapted to the Spanish health care perspective, using local costs obtained from the literature or hospital databases. As observed in AiDAPT, women treated with AID began with an average glycated hemoglobin (HbA1c) of 7.6% (\u00b11.1) and reached a post-treatment average of 6.0% (\u00b10.5), demonstrating significant improvement in glycemic control. However, in the model, clinical outcomes and the resulting cost impact are based on the incremental 0.3% HbA1c reduction from the first to the third trimester using AID over SoC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Using CamAPS FX AID instead of SoC in pregnancies complicated by T1D resulted in estimated cost savings of \u20ac1,002 per treated woman for the Spanish health care system within the first year of treatment. Of these cost savings, the majority (81%) were driven by reductions in intensive neonatal care admissions, reflecting not only marked financial savings but, more importantly, a reduction in complications and suffering among newborns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This conservative analysis captures a clinically significant impact and subsequent economic value, despite being based on only a limited number of perinatal complications. This study provides valuable insights to guide clinical practice, shape health care decision-making, and support broader adoption of technologies that improve maternal and neonatal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15209156261423217","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T04:33:01Z","timestamp":1771389181000},"page":"933-940","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing Diabetes Management During Type 1 Diabetes Pregnancy with Automated Insulin Delivery Therapy: Clinical Impact and Economic Consequences in Spain"],"prefix":"10.1177","volume":"28","author":[{"given":"Pilar I.","family":"Beato-V\u00edbora","sequence":"first","affiliation":[{"name":"Badajoz University Hospital, Badajoz, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Eleni","family":"Syleouni","sequence":"additional","affiliation":[{"name":"mylife Diabetes Care AG, Burgdorf, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara T.M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK."},{"name":"Diabetes and Antenatal Care, Norfolk and Norwich NHS Foundation Trust, Norwich, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aesha","family":"Khan-Mir\u00f3n","sequence":"additional","affiliation":[{"name":"mylife Diabetes Care AG, Burgdorf, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Quiros","sequence":"additional","affiliation":[{"name":"Hospital Universitari Mutua de Terrassa, Terrassa, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Carrieri","sequence":"additional","affiliation":[{"name":"Department of Medicine and Aging Sciences, Center for Advanced Studies and Technology-CAST, University G. D\u2019Annunzio of Chieti-Pescara, Chieti, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK."},{"name":"Diabetes and Antenatal Care, Norfolk and Norwich NHS Foundation Trust, Norwich, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.04.007"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/IJERPH191710846"},{"key":"e_1_3_2_4_2","volume-title":"Recommendations | Diabetes in pregnancy: management from preconception to the postnatal period | Guidance","author":"NICE","year":"2015","unstructured":"NICE. Recommendations | Diabetes in pregnancy: management from preconception to the postnatal period | Guidance. NICE. 2015."},{"key":"e_1_3_2_5_2","unstructured":"Grupo espa\u00f1ol de diabetes y embarazo sociedad espa\u00f1ola de diabetes sociedad espa\u00f1ola de ginecolog\u00eda y obstetricia. Gu\u00eda De Pr\u00e1ctica Cl\u00ednica Para Diabetes Mellitus y Embarazo 2020."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/CLINEM\/DGAB769"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/DC16-1647"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.2337\/DC11-0244"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/DIA.2021.0073"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/JCM13247740"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/JCM9020582"},{"key":"e_1_3_2_12_2","first-page":"35","article-title":"36 sociedad espa\u00f1ola de ginecolog\u00eda y obstetricia diabetes pregestacional","volume":"65","author":"Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia","year":"2022","unstructured":"Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia. 36 sociedad espa\u00f1ola de ginecolog\u00eda y obstetricia diabetes pregestacional. Prog Obstet Ginecol, 2022; 65:35\u201341.","journal-title":"Prog Obstet Ginecol"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.endien.2021.12.006"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/S00592-025-02446-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2025.113969"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231223934"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2303911"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2025.19578"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.ECLINM.2025.103106"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1089\/DIA.2023.0594"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00089-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251379488"},{"key":"e_1_3_2_23_2","unstructured":"Syleouni M-E Khan Mir\u00f3n A Lee T et al. Improving HBA1C on 3RD trimester type 1 diabetes pregnancy with camaps FX: CLINICAL and economic outcomes. In: 18th International Congress on Advanced Treatments and Technologies for Diabetes (ATTD) Amsterdam; 2025."},{"key":"e_1_3_2_24_2","unstructured":"Ministerio de Sanidad C y BS. Subdirecci\u00f3n General de Informaci\u00f3n Sanitaria. Registro de Actividad de Atenci\u00f3n Especializada \u2013 RAE-CMBD. 2020. Available from: https:\/\/pestadistico.inteligenciadegestion.mscbs.es\/PUBLICOSNS"},{"key":"e_1_3_2_25_2","unstructured":"Oblikue consulting. ESalud\u2014Informaci\u00f3n Econ\u00f3mica Del Sector Sanitario. n.d. Available from: http:\/\/oblikue.com\/bddcostes\/ [Last accessed: June24 2025]."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.REUMA.2020.09.006"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.JVAL.2021.11.1351"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/DIA.2023.0323"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/S00125-024-06216-2"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01142-7"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1670804"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707943"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/CLINEM\/DGAA931"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.1585"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00340-1"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156261423217","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15209156261423217","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156261423217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:36:19Z","timestamp":1788435379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15209156261423217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["10.1177\/15209156261423217"],"URL":"https:\/\/doi.org\/10.1177\/15209156261423217","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}